Results

Total Results: 1,078 records

Showing results for "stage".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
    September 01, 2014 - , designated as “T”), the extent of local or regional lymph node spread (nodal stage, designated as … However, stage is the key determinant of the management strategy. … Stage reclassification or clinical decision impact. … tomography; T = tumor stage. … ; OR = odds ratio; T = tumor stage.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
    September 26, 2023 - Treatment of Stage I-III Squamous Cell Anal Cancer Evidence-based Practice Center Systematic Review … Protocol Project Title: Treatment of Stage I-III Squamous Cell Anal Cancer Publication Date: August … Stage Definition I T1 (tumor ≤2 cm in greatest dimension, no nodal involvement (N0), and no distant … Treatment compliance in early-stage anal cancer. Ann Oncol. 2020 Oct;31(10):1282-1284. 14. … s or restaging or stage or staging or status or recurrent or recurrence or relapse?)).
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
    December 01, 2012 - While adjuvant chemotherapy is recommended in patients with stage III colon cancer, its role in stage … Publications That Did Not Provide Specific Results for Stage II Colon Cancer 1 Background Stage … 1) and stage D (Stage IV) colorectal cancer. … A or stage D. … T-stage, N-stage and MSI status.
  4. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
    August 01, 2022 - 0" or "stage 1" or "stage 1a" or "stage 1b" or "stage 2" or "stage 2a" or "stage 2b" or "stage I" or … "stage Ia" or "stage Ib" or "stage II" or "stage IIa" or "stage IIb" or "stage zero" or "stage one" … 0" or "stage 1" or "stage 1a" or "stage 1b" or "stage 2" or "stage 2a" or "stage 2b" or "stage I" or … "stage Ia" or "stage Ib" or "stage II" or "stage IIa" or "stage IIb" or "stage zero" or "stage one" … stage I" OR EXPAND[Concept] "stage Ia" OR EXPAND[Concept] "stage Ib" OR EXPAND[Concept] "stage II" OR
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
    February 22, 2012 - Analytical framework for comparative effectiveness of local curative (stage IIIa) or palliative (stage … I" OR "stage one" OR "stage 1" OR T1N0M0 OR T2N0M0 OR early OR inoperable OR unoperable OR nonoperable … III" OR "stage 3" OR "stage three" OR "stage IIIa" OR "stage IIIb" OR "stage IV" OR "stage 4" OR "stage … I" OR "stage one" OR "stage 1" OR T1N0M0 OR T2N0M0 OR early OR inoperable OR unoperable OR nonoperable … iii' OR 'stage 3' OR 'stage three' OR 'stage iiia' OR 'stage iiib' OR 'stage iv' OR 'stage 4' OR 'stage
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-risk-of-bias.pdf
    December 01, 2017 - Stage 2. … Stage 3. … Stage 4. … Stage 4. … Stage 2. Pilot Test and Train Stage 3.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
    November 01, 2024 - CKD stage 4 represents severe kidney damage. … CKD stage 5, representing severe kidney damage or failing kidneys and also termed as end stage kidney … Treatment for CKD stage 5 patients is dialysis or kidney replacement therapy. … 4 or 5 • CKD 4 + hemodialysis • End stage renal disease + hemodialysis • End stage renal disease … or dysfunction* or insufficien*)).ti,ab. 109054 3 (end stage renal or end stage kidney or kidney
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - diagnosed with stage II disease are between 58 and 83 percent. … those with resected stage II disease will develop recurrence or die from their disease. … II disease but did not provide stage II-specific results.) … predicted outcomes in patients with stage II colon cancer? … colon cancer: has the time finally arrived, or are we still stage locked?
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
    December 14, 2012 - Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage … Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer. Technical Brief. … (and stage subgroups) separates patients into prognostic subsets. … Nitsche reported that ColoPrint identified most stage II patients (73%) as low risk. … Tabernero reported “ColoPrint classifies two-thirds of the stage II patients as Low Risk.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - This is an understatement since the standard of care for stage II and III rectal cancer is neoadjuvant … Table A: The table shows specificity of T1 stage as 75.8. … For preoperative rectal cancer T (tumor) staging, ERUS is less likely than CT to incorrectly stage ( … Specifically, most of the analyses on T-stage did not distinguish the strengths of ultrasound vs MRI … late T-stage extent.
  11. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - effect.29–31 No study contained only stage II patients, and in the study with the most stage II patients … affected the surgery choices for both stage I and stage II patients, whereas the local area BCSI rate … affected only the surgery choices for stage II patients and did not affect the surgery choices for stage … linear probability model and the IV estimates using combined stage I and stage II patients are consistently … Patient Groups Per Instrument ESBC Patients All (N � 6185) Stage I (N � 3280) Stage II (N � 2905
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
    January 01, 2023 - ES 95% CI SE P-Value Favors Strength 25721185 Torp 2015 GPA NordLOTS, stage 1 14 weeks (post-treatment … Gender NR B 0.35  -1.79 to 2.49 0.75 NS Neutral (Nonsignificant) 25721185 Torp 2015 GPA NordLOTS, stage … 0.86 0.04 7-11 Strength unclear (Continuous predictors; P<0.05) 25721185 Torp 2015 GPA NordLOTS, stage … ≥22 vs <22 B 0.06 -0.01 to 0.13 0.83 NS Neutral (Nonsignificant) 25721185 Torp 2015 GPA NordLOTS, stage … Yes vs no B 1.18 -1.33 to 3.69 0.356 NS Neutral (Nonsignificant) 25721185 Torp 2015 GPA NordLOTS, stage
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
    June 12, 2013 - Disposition of Comments for Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non-Small-Cell … The CER is about local, nonsurgical interventions for stage I NSCLC. … There is a lack of analysis for RFA of medically inoperable stage I NSCLC. … Stereotactic body radiation therapy for inoperable early stage lung cancer. … , not “local therapies for stage I” lung cancer as stated.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - 2: Kidney damage with GFR 60-89 mL/min/1.73 m2 • Stage 3: GFR 30-59 mL/min/1.73 m2 • Stage 4: GFR … (2) Albuminuria stages should be added within each GFR stage (urinary ACR <30 mg/g, 30-299 mg/g … Epidemiology of CKD Based on the K/DOQI CKD definition and stage classification, and utilizing a … Of the population,1.8% (3.6 million) individuals were classified in stage 1 CKD, 3.2% (6.5 million) … in stage 2 CKD, 7.7% (15.5 million) in stage 3 CKD, and 0.4% (0.7 million) in stage 4 CKD.3 U.S.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
    June 01, 2013 - 1 Comparative Effectiveness Review Number 112 Local Nonsurgical Therapies for Stage I and Symptomatic … I, stage II, and selected stage III tumors) • Potentially operable or inoperable locally (T3–T4) … Several radiotherapy modalities have been used to treat patients with stage I NSCLC. … Surgery is the standard of care for eligible patients with stage I NSCLC. … The treatment of early-stage disease. Semin Radiat Oncol. 2010 Jul;20(3):178-85.
  16. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
    May 01, 2020 - of labor (low SOE) or duration of the second stage of labor (low SOE). … The natural history of the normal first stage of labor. … Effects of LI4 acupressure on labor pain in the first stage of labor. … Upright position during the first stage of labor: a randomised controlled trial. … Maternal positions and mobility during first stage labour.
  17. effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
    May 29, 2025 - training manual o Remains flexible Slide 25 Facilitation tools: Ice breakers • Ice breakers o Stage … 1: Getting to know you o Stage 2: Understanding the process o Stage 3: Creating a community Slide … 26 Facilitation tools: Ice breakers • Ice breakers o Stage 1: Getting to know you Image: There … Slide 27 Facilitation tools: Ice breakers • Ice breakers o Stage 2: Understanding the process Image … Slide 28 Facilitation tools: Ice breakers • Ice breakers o Stage 3: Creating a community Image
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
    November 01, 2020 - (Stage 3). … on monthly update searches (Stage 3). … Stage 2: Test Machine Learning Classifier on Optimized Searches In Stage 2, we aimed to develop machine … Background Methods Stage 1: Develop Optimized Search Strategies Stage 2: Test Machine Learning Classifier … Search Strategies Stage 2: Test Machine Learning Classifier on Optimized Searches Stage 3: Test Machine
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
    January 01, 2019 - Chance a likely explanation or unclear Interaction p-value is 0.018 for stage IIIB vs. IIIA. … No "dose-response effect" across stage severity apparent. 47262 Shin 2019 Pathological stage Yes Overall … Chance a very likely explanation Interaction p-value is 0.09 for stage IIIC vs. IIIA. … No "dose-response effect" across stage severity apparent. 40444 ITACA-S Pathological stage Yes Overall … No "dose-response effect" across stage severity apparent. 50261 PRODIGY Clinical stage Yes Overall survival
  20. effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Diabetes Diabetes Rate in Enrolled Population Total All 2006 32.8 8.7 26.4% Age Disabled/end stage … American Indian/Alaska Native 2006 0.1 0.1 36.0% Total All 2007 32.3 8.8 27.3% Age Disabled/end stage … American Indian/Alaska Native 2007 0.2 0.1 37.3% Total All 2008 31.9 8.9 27.9% Age Disabled/end stage … Beneficiaries With Diabetes and Without PAD Total All 2006 8.1% 19.2% 5.0% Age Disabled/end stage … Beneficiaries With Diabetes and Without PAD Total All 2006 1.8% 6.5% 0.6% Age Disabled/end stage

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: